Sign in
  Edit search
Pharmacokinetic study of saquinavir hard gel caps%2Fritonavi…
Pharmacokinetic study of saquinavir hard gel caps%2Fritonavir in HIV-1-infected patients%3A 1600%2F100 mg once-daily compared with 2000%2F100 mg once-daily and 1000%2F100 mg twice-daily.
Pharmacokinetic study of saquinavir hard gel caps%2Fritonavir in HIV-1-infected patients%3A 1600%2F100 mg once-daily compared with 2000%2F100 mg once-daily and 1000%2F100 mg twice-daily.
Article, Chapter
Authors: R.S. Autar
Publication: Journal of Antimicrobial Chemotherapy, Volume:54, Issue:4, Page(s):785-790
ISSN: 0305-7453
  Full text availability for this item
View Full Text Source:Journal of Antimicrobial Chemotherapy,Journal of Antimicrobial Chemotherapy,Oxford University Press Journals (UKB 2021-2023) Opens in new Window
Journal:  Journal of Antimicrobial Chemotherapy Source:Oxford University Press Journals (UKB 2021-2023) Opens in new Window
Collection:  Oxford University Press Journals (UKB 2021-2023)
Coverage:
  • 1996~present; volume:37~present;issue:1~present
Browse related articles
  Print copies at your library
Check availability in RUQuest
  Request a copy of this item
Cite this item